Frank E. Thomas
2013
In 2013, Frank E. Thomas earned a total compensation of $1.2M as President and Chief Operating Officer at AMAG Pharmaceuticals, a 28% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,500 |
|---|---|
| Option Awards | $314,858 |
| Salary | $423,077 |
| Stock Awards | $216,265 |
| Other | $7,650 |
| Total | $1,174,350 |
Thomas received $423.1K in salary, accounting for 36% of the total pay in 2013.
Thomas also received $212.5K in non-equity incentive plan, $314.9K in option awards, $216.3K in stock awards and $7.7K in other compensation.
Rankings
In 2013, Frank E. Thomas' compensation ranked 5,934th out of 12,286 executives tracked by ExecPay. In other words, Thomas earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,934 out of 12,286 | 52nd |
Division Manufacturing | 2,060 out of 4,612 | 55th |
Major group Chemicals And Allied Products | 602 out of 1,462 | 59th |
Industry group Drugs | 432 out of 1,156 | 63rd |
Industry Pharmaceutical Preparations | 347 out of 890 | 61st |
Source: SEC filing on April 15, 2016.
Thomas' colleagues
We found five more compensation records of executives who worked with Frank E. Thomas at AMAG Pharmaceuticals in 2013.
2013
Greg Madison
AMAG Pharmaceuticals
Former Executive Vice President and Chief Commercial Officer
2013
William Heiden
AMAG Pharmaceuticals
Chief Executive Officer
2013
Christopher White
AMAG Pharmaceuticals
Senior Vice President and Chief Business Officer
2013
Scott Townsend
AMAG Pharmaceuticals
General Counsel
2013
Scott Holmes
AMAG Pharmaceuticals